Peer-influenced content. Sources you trust. No registration required. This is HCN.
News Medical
Statin exposure in LPS-primed mouse muscle cells activated NLRP3 inflammasome signaling and reduced protein prenylation, producing atrophy markers and grip strength loss in a preclinical model of statin myopathy.
Cardiology June 29th 2026
Annals of Internal Medicine
The American College of Physicians issued a living clinical guideline recommending semaglutide and tirzepatide as first-line pharmacologic treatments with lifestyle modifications for nonpregnant adults with obesity (BMI 30 kg/m2 or higher) or overweight (BMI 27 to 30 kg/m2) with at least one weight-related comorbidity, with phentermine-topiramate, liraglutide, and naltrexone-bupropion designated as second-, third-, and fourth-line options respectively based on GRADE evidence review.
Ambulatory Care Pharmacy (BCACP) June 24th 2026
MDLinx
Celebrity disclosures about using beta blockers for performance anxiety are prompting patient questions in primary care, reviving a decades-old off-label use with a comparatively lower risk profile than benzodiazepines.
Cardiology June 22nd 2026
Healthline
Several recent studies link daily avocado consumption to lower dietary glycemic load, reduced diabetes risk in women, and modest blood pressure improvements in prediabetes patients, though small sample sizes and short follow-up periods limit the conclusions.
Medical News Today (MNT)
A 31,000-patient observational study found that dihydropyridine calcium-channel blockers were associated with a 33% higher risk of major adverse kidney events in type 2 diabetes patients already on RASi and SGLT2i therapy.
Clinical Advisor
A man in his early 30s presenting with post-viral chest pain and bilateral forearm numbness posed a diagnostic challenge when automated ECG interpretation missed findings later consistent with acute pericarditis, including diffuse concave-upward ST elevation, PR depression, and a positive Spodick sign.
Cardiology June 18th 2026